NAPA anesthesia appoints Kathryn Cullen as President of Clinical Services. PR Newswire SUNRISE, Fla., May 4, 2026 /PRNewswire/ - North American Partners in Anesthesia (NAPA), the nation's leading single-specialty anesthesia management company, has appointed Kathryn Cullen as President of the Clinical Services division. In this role, Cullen will lead NAPA's clinical services strategy, partnering closely with clinicians and operational leaders to strengthen client relationships and support our local anesthesia teams. Cullen has extensive experience leading large-scale, multi-site healthcare operations, with a focus on performance transformation, physician partnership, and sustainable growth. "Kathryn is a proven operator with a demonstrated ability to bring structure, accountability, and momentum to complex healthcare environments," said Rafael Cartagena, MD, NAPA's Chief Executive Officer. "Her ability to align priorities and drive change positions her to further advance how we deliver value." Most recently, Cullen served as Senior Vice President of Operations and Corporate Development at Radiology Partners, where she oversaw approximately $800 million in revenue across multiple regions. She led improvement efforts in underperforming markets and implemented the organization's first client-facing dashboard to enhance physician engagement and retention. Earlier in her career, Cullen held senior leadership roles at West Dermatology and DaVita, where she led integrated operations and initiatives to improve clinical outcomes, expand access to care, and drive financial performance. At DaVita, she oversaw more than 150 dialysis facilities and a $650 million P&L, consistently delivering top-tier results in service, quality, and outcomes. "I've spent my career seeking out environments to work with great healthcare leaders who have a mandate to solve complex patient care challenges," said Cullen. "NAPA's commitment to excellence through its clinician-led model creates a powerful foundation for innovation and partnership. I'm excited to join this team and help advance the impact we make together." About North American Partners in Anesthesia As a clinician-led organization, North American Partners in Anesthesia (NAPA) continues to redefine healthcare, delivering industry-leading excellence nationwide to its partners and patients. With 40 years of clinical services experience, we serve millions of patients annually at hundreds of healthcare facilities. This expertise informs our managed services in anesthesia-driven revenue cycle solutions, talent and workforce strategies, and perioperative consulting. For more information, please visit NAPAanesthesia.com.

Radiology Partners, the leading technology-enabled radiology practice in the US, has appointed former Maryland Governor Larry Hogan to its board of directors. Hogan, who served as the state's 62nd governor from 2015 to 2023, is a cancer survivor and former chairman of the National Governors Association. During his tenure, Hogan launched Maryland's $216 million Cancer Moonshot initiative to expand cancer detection, treatment and research. His administration also guided the state through the pandemic, coordinating testing, vaccination and care delivery efforts. The appointment brings public health expertise and healthcare policy experience to support Radiology Partners' physician-led mission. The company serves over 3,400 hospitals and healthcare facilities across the United States, focusing on clinical innovation and AI-driven solutions to improve patient outcomes.

Cognita, the AI business unit of Mosaic Clinical Technologies, has received FDA Breakthrough Device Designation for its Cognita Chest X-Ray system, a generative vision-language model designed to assist radiologists in interpreting chest X-rays. It is the first radiology generative AI model to receive this designation. The system analyses chest X-rays and generates comprehensive preliminary findings for radiologist review. Internal clinical validation showed participating radiologists achieved enhanced detection of up to 16-65% for certain significant findings and an 18% boost in average interpretation efficiency. Mosaic Clinical Technologies is a wholly-owned subsidiary of Radiology Partners, the largest radiology practice in the US with over 4,000 radiologists. The FDA's Breakthrough Device Programme accelerates development of technologies that may significantly improve patient care for life-threatening conditions.